Cancer Discovery

Published by: American Association for Cancer Research  

People

  1. Schram
    Schram
  2. Berger
    Berger
  3. Solit
    Solit
  4. Chakravarty
    Chakravarty
  5. De Stanchina
    De Stanchina
  6. Drilon
    Drilon
  7. Ladanyi
    Ladanyi
  8. Razavi
    Razavi
  9. Schultz
    Schultz
  10. Arcila
    Arcila

Groups

  1. Department of Medicine (18)
  2. Gynecologic Medicine Service (18)
  3. Solid Tumor Oncology Division (18)
  4. GSK Faculty (12)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (10)
  6. Department of Pathology and Laboratory Medicine (10)
  7. GDMT, Medicine (10)
  8. Gynecology Disease Management Team (10)
  9. Human Oncology and Pathogenesis Program (10)
  10. Early Drug Development Service (9)
Search Within
  1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (16)
  2. Editorial (1)
  3. Review (1)
Groups
  1. Department of Medicine (18)
  2. Gynecologic Medicine Service (18)
  3. Solid Tumor Oncology Division (18)
  4. GSK Faculty (12)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (10)
  6. Department of Pathology and Laboratory Medicine (10)

More Groups

People
  1. Alison Schram (8)
  2. Michael Berger (7)
  3. David Hyman (6)
  4. David Solit (6)
  5. Barry Taylor (5)
  6. Alexander Drilon (4)

More People

Years
  1. 2024 (3)
  2. 2023 (2)
  3. 2022 (4)
  4. 2021 (3)
  5. 2020 (2)
  6. 2018 (1)

More Years

Publishers
  1. American Association for Cancer Research (18)

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Advancing global health equity in oncology clinical trial access
    Editorial

    Bloomberg New Economy International Cancer Coalition; McKinsey Cancer Center; Cure4Cancer
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Discovery and clinical proof-of-concept of RLY-2608, a first-in-class mutant-selective allosteric PI3Kα inhibitor that decouples antitumor activity from hyperinsulinemia
    Journal Article

    Varkaris, A.; Pazolli, E.; Gunaydin, H.; Wang, Q.; Pierce, L.; Boezio, A. A.; Bulku, A.; DiPietro, L.; Fridrich, C.; Frost, A.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Quantifying the expanding landscape of clinical actionability for patients with cancer
    Journal Article

    Suehnholz, S. P.; Nissan, M. H.; Zhang, H.; Kundra, R.; Nandakumar, S.; Lu, C.; Carrero, S.; Dhaneshwar, A.; Fernandez, N.; Xu, B. W.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations
    Journal Article

    Subbiah, V.; Sahai, V.; Maglic, D.; Bruderek, K.; Touré, B. B.; Zhao, S. P.; Valverde, R.; O'Hearn, P. J.; Moustakas, D. T.; Schönherr, H.; more...
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Molecular characterization of endometrial carcinomas in black and white patients reveals disparate drivers with therapeutic implications
    Journal Article

    Weigelt, B.; Marra, A.; Selenica, P.; Rios-Doria, E.; Momeni-Boroujeni, A.; Berger, M. F.; Arora, K.; Nemirovsky, D.; Iasonos, A.; Chakravarty, D.; more...
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Genetic ancestry correlates with somatic differences in a real-world clinical cancer sequencing cohort
    Journal Article

    Arora, K.; Tran, T. N.; Kemel, Y.; Mehine, M.; Liu, Y. L.; Nandakumar, S.; Smith, S. A.; Brannon, A. R.; Ostrovnaya, I.; Stopsack, K. H.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Tumor-derived lysophosphatidic acid blunts protective type I interferon responses in ovarian cancer
    Journal Article

    Chae, C. S.; Sandoval, T. A.; Hwang, S. M.; Park, E. S.; Giovanelli, P.; Awasthi, D.; Salvagno, C.; Emmanuelli, A.; Tan, C.; Chaudhary, V.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Zenocutuzumab, a HER2XHER3 bispecific antibody, is effective therapy for tumors driven by NRG1 gene rearrangements
    Journal Article

    Schram, A. M.; Odintsov, I.; Espinosa-Cotton, M.; Khodos, I.; Sisso, W. J.; Mattar, M. S.; Lui, A. J. W.; Vojnic, M.; Shameem, S. H.; Chauhan, T.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Atezolizumab treatment of tumors with high tumor mutational burden from MyPathway, a multicenter, open-label, phase IIa multiple basket study
    Journal Article

    Friedman, C. F.; Hainsworth, J. D.; Kurzrock, R.; Spigel, D. R.; Burris, H. A. 3rd; Sweeney, C. J.; Meric-Bernstam, F.; Wang, Y.; Levy, J.; Grindheim, J.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save

    • Cancer Discovery – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Discovery 21598290 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer Discovery 2159-8274 Unknown
    Cancer Discovery 21598274 American Association for Cancer Research
    Cancer Discovery 21598290 American Association for Cancer Research
    Cancer discovery 21598290 The Authors the American Association for Cancer Research
    Cancer Discovery 21598274 American Association for Cancer Research
    Cancer discovery 21598290 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer discovery 21598290 American Association for Cancer Research
    Cancer Discovery 2159-8290 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer discovery 2159-8290 American Association for Cancer Research
    Cancer Discovery 21598274 Unknown
    Cancer Discovery 21598274 American Association for Cancer Research
    Cancer Discovery 21598274 American Association for Cancer Research
    Cancer Discovery 21598274 The Authors
    Cancer Discovery 21598274 The Authors the American Association for Cancer Research
    Cancer Discovery 21598274 The Authors the American As Sociation for Cancer Research
    Cancer discovery 21598290 Unknown